We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Telemetry Reveals Stroke Patients' Cardiac Problems

By HospiMedica staff writers
Posted on 13 Mar 2006
To detect "silent” or new cardiac abnormalities, all patients hospitalized for stroke should be under continuous cardiac rhythm monitoring (telemetry) for at least the first 24 hours after the stroke is detected, according to a new study. More...


Researchers at Loyola University (Chicago,IL, USA) reviewed records of 337 stroke patients, 289 of them placed on telemetry. Among the telemetry patients, 80% had normal rhythms, but the remainder had abnormal rhythms. Results of the study showed that 17% of the patients placed on telemetry developed new cardiac rhythms while monitored. New-onset atrial fibrillation was detected in 22 (7.6%) of all patients monitored on telemetry.

Cardiovascular risk factors were discovered more frequently in the patients placed on telemetry as compared to those who were not monitored. In addition, patients whose cardiac rhythms changed following admission had a higher percentage of coronary artery disease than those whose rhythms remained static. All patients found to have a new rhythm following telemetry monitoring had no previous history of arrhythmia. The authors therefore suggest that upon admission to the hospital, all patients should be monitored. The findings were presented at the American Stroke Association's international conference, held in February 2006 in Kissimmee (Florida, USA).

"Many patients have paroxysmal or otherwise ‘silent' arrhythmias, which may not show up until after a stroke occurs, said study co-author Dr. Michael J. Schneck, director of the neuro-intensive care program at Loyola University's health system. "Continuous cardiac rhythm monitoring allows for the discovery of unsuspected paroxysmal abnormalities, such as atrial fibrillation, which may be important in determination of antithrombotic therapy post stroke. It is well-known that there is a strong association between this rhythm and ischemic cardioembolic stroke. It also is important to identify these dysrhythmias as early as possible in order to prevent the progression of infarct size with subsequent worsening neurologic deficits.”



Related Links:
Loyola University Chicago

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.